| August 06, 2007 |
![]() |
||||||||||
|
In This Issue:
California Medi-Cal: |
|||||||||||
|
Updated CARCs and RARCs |
||||||||||||||||||||||
CMSTransmittal 1267: CR5634 (PDF).
Change Request 5634 which instructs Medicare contractors that a Remittance Advice Remark Code
(RARC) must be used with Claim Adjustment Reason Codes (CARCs) 16, 17, 96, 125, and A1. The code
committee that maintains the CARC code set recently modified five CARCs (16, 17, 96, 125, and A1).
These CARCs were selected for modification because they were very generic, and they were used most
frequently. Of these 5 CARCs, the following 4 now require the use of at least one appropriate RARC,
and they are effective April 1, 2007:
|
||||||||||||||||||||||
|
Top 10 Duplicate Claim Submitters |
CMSCMS continues to focus identification of provider compliance errors on duplicate claim denials through the CERT review process, which indicates the following specialties as high volume duplicate submitters: Specialty % of claim denials for California
Duplicate billing is not cost effective for the Medicare program. Duplicate submissions are also the number one reason for poor provider compliance in the CERT review. Remember, duplicate billing is considered abusive by CMS and can result in additional auditing of providers. Carriers suggest that providers post payments and denials promptly and review denials in order to take the appropriate action.
|
|
New CLIA Waived Tests |
|||||||||||||||||||||||||||
CMSTransmittal 1244: CR5600 (PDF).
Laboratory claims are currently edited at the CLIA certificate level in order to ensure that CMS only pays for laboratory tests categorized as waived complexity under CLIA (for facilities with a CLIA certificate of waiver). Listed below are the latest tests approved by the Food and Drug Administration as waived tests under the CLIA. CPT codes for the following new tests must have the modifier QW to be recognized as a waived test.
|
|
NPPES Errors, Using the NPI on Medicare Claims |
CMSMedicare Learning Network: SE0725 (PDF).
Important Information for Providers/Suppliers Regarding National Plan and Provider Enumeration System (NPPES) Errors, Using the NPI on Medicare Claims and 835 Remittance Advice Changes Common Enumeration Errors in NPPES
Dos and Don’ts When Reporting “Other Provider Identification Numbers” in NPPES
If Medicare providers/suppliers determine that they should make changes to their NPPES records, they may do so by going to NPPES at https://nppes.cms.hhs.gov/ at any time and updating their information.
|
|
Medi-Cal begins using 2007 CPT-4 codes August 1, 2007 |
California Medi-CalMedi-Cal General Medicine: Bulletin 397 (PDF).
Effective August 1, 2007, Medi-Cal will adopt the 2007 CPT-4 and HCPCS Level II codes. Claims billed for dates of service on or after August 1, 2007 must use the appropriate 2007 codes.
|
|
Diagnosis code restrictions for 83001 and 83002 effective August 1, 2007 |
|||||||||||||||||||||||||||||||||||||||||||||
California Medi-CalMedi-Cal General Medicine: Bulletin 397 (PDF). Effective for dates of service on or after August 1, 2007, CPT-4 codes 83001 (gonadotropin; follicle stimulating hormone [FSH]) and 83002 (…luteinizing hormone [LH]) are reimbursable only when billed in conjunction with one of the following ICD-9-CM diagnosis codes:
Codes 83001 and 83002 should only be ordered when medically indicated, based on patient evaluation. Gonadotropin level tests for screening or non-indicated disease processes are not medically justified, and therefore, not reimbursable. ICD-9-CM codes 403.0 – 403.9, 404.0 – 404.9 and 571.0 – 571.9, that were previously supported in connection with codes 83001 and 83002, have been deleted.
| |||||||||||||||||||||||||||||||||||||||||||||